Infiltration of Th17 in tumor microenvironment has been shown to promote tumor growth and angiogenesis, through induction of angiogenic factors (vascular endothelial growth factor/VEGF and prostaglandin E2/PGE2) and activation of oncogenic IL-6/Stat3 signaling (206, 207). This evidence concerns the gene IL6 and neoplasm.